News | July 31, 2025
Asahi Kasei Life Science to construct new plant for Planova virus removal filters
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The company showcased three core programs developed through this platform
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
